{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:01:05Z","timestamp":1784764865943,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.maturitas.2026.109004","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:03:43Z","timestamp":1779951823000},"page":"109004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genitourinary syndrome of menopause in women with cancer \u2013 a narrative review"],"prefix":"10.1016","volume":"211","author":[{"given":"H.M.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2026.109004_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2019.08.043","article-title":"Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy","volume":"222","author":"Crean-Tate","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0010","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1245\/s10434-023-13907-4","article-title":"Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects","volume":"30","author":"Rojas","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.2022.24140","article-title":"Management of Menopausal Symptoms: A Review","volume":"329","author":"Crandall","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2026.109004_bb0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/13697137.2023.2184253","article-title":"Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies","volume":"26","author":"Castelo-Branco","year":"2023","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109004_bb0025","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Vulvovaginal Atrophy Terminology Consensus Conference Panel, Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109004_bb0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9378(81)90710-9","article-title":"Estrogen receptors in the human female lower urinary tract","volume":"141","author":"Iosif","year":"1981","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2018.08.008","article-title":"Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials","volume":"229","author":"Pitsouni","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/GME.0000000000001570","article-title":"Variation in outcome reporting and measurement tools in clinical trials of treatments for genitourinary symptoms in peri- and postmenopausal women: a systematic review","volume":"27","author":"Christmas","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109004_bb0045","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/GME.0000000000001406","article-title":"Critical analysis of methods for assessing genitourinary syndrome of menopause used in clinical trials","volume":"26","author":"Lima","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109004_bb0050","doi-asserted-by":"crossref","first-page":"99.e1","DOI":"10.1016\/j.ajog.2019.12.270","article-title":"Patient-centered change in the day-to-day impact of postmenopausal vaginal symptoms: results from a multicenter randomized trial","author":"Gibson","year":"2020","journal-title":"Am. J. Obstet. Gynecol., Mosby Inc"},{"key":"10.1016\/j.maturitas.2026.109004_bb0055","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","article-title":"Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists","volume":"17","author":"Biglia","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.maturitas.2026.109004_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109004_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2024.08.022","article-title":"Patient-reported sexual health outcomes of cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy","volume":"190","author":"Chuk","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.49822","article-title":"Vaginal Estrogen Utilization Among Medicare Beneficiaries With Genitourinary Syndrome of Menopause","volume":"8","author":"Gallo","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.maturitas.2026.109004_bb0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clbc.2015.06.005","article-title":"Genitourinary syndrome of menopause in breast cancer survivors: Are we facing new and safe hopes?","volume":"15","author":"Biglia","year":"2015","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.maturitas.2026.109004_bb0085","first-page":"85","article-title":"Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy","volume":"33","author":"Galhardo","year":"2006","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0090","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(23)02802-7","article-title":"Managing menopause after cancer","volume":"403","author":"Hickey","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2026.109004_bb0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/13697137.2021.1891218","article-title":"Sustainability of vaginal estrogens for genitourinary syndrome of menopause\u2013a systematic review","volume":"24","author":"Weidlinger","year":"2021","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109004_bb0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/20533691241286666","article-title":"British gynaecological cancer society and British menopause society guidelines: management of menopausal symptoms following treatment of gynaecological cancer","volume":"30","author":"Taylor","year":"2024","journal-title":"Post Reprod. Health"},{"key":"10.1016\/j.maturitas.2026.109004_bb0105","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/AOG.0b013e3181f386bb","article-title":"Endometrial Safety of Ultra-Low-Dose Estradiol Vaginal Tablets","volume":"116","author":"Simon","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0110","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1097\/01.AOG.0000463542.93964.91","article-title":"Topical Vaginal Estrogen Use and Risk of Endometrial Hyperplasia or Cancer [24]","volume":"125","author":"Gunnison","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women\u2019s Health Initiative Observational Study","volume":"25","author":"Crandall","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109004_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/GME.0000000000001463","article-title":"Systemic estradiol levels with low-dose vaginal estrogens","volume":"27","author":"Santen","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109004_bb0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0378-5122(82)90061-5","article-title":"The pharmacology of oestriol","volume":"4","author":"van der Vies","year":"1982","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109004_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2016.06.017","article-title":"Clinical effects of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women","volume":"91","author":"Coelingh Bennink","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109004_bb0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/13697137.2021.1998436","article-title":"Efficacy of low-dose vaginal 17\u03b2-estradiol versus vaginal promestriene for vulvovaginal atrophy","volume":"25","author":"Palacios","year":"2022","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109004_bb0145","doi-asserted-by":"crossref","DOI":"10.11144\/Javeriana.umed65.espt","article-title":"Eficacia y seguridad del promestrieno en el tratamiento del s\u00edndrome genitourinario de la menopausia en mujeres con c\u00e1ncer de mama","volume":"65","author":"Espitia De La Hoz","year":"2024","journal-title":"Universitas M\u00e9dica"},{"key":"10.1016\/j.maturitas.2026.109004_bb0150","author":"NICE"},{"key":"10.1016\/j.maturitas.2026.109004_bb0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/JU.0000000000004589","article-title":"The AUA\/SUFU\/AUGS Guideline on Genitourinary Syndrome of Menopause","volume":"214","author":"Kaufman","year":"2025","journal-title":"J. Urol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0160","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00192-021-04832-9","article-title":"The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections","volume":"8","author":"Anglim","year":"2022","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.maturitas.2026.109004_bb0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract Infections","volume":"329","author":"Raz","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2026.109004_bb0170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2020.02.028","article-title":"Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study","volume":"157","author":"Chang","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ygyno.2017.12.025","article-title":"Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study","volume":"148","author":"Soisson","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0180","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/bjc.2011.315","article-title":"Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study","volume":"105","author":"Lind","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.maturitas.2026.109004_bb0185","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/pon.3461","article-title":"Bladder and Bowel Symptoms in Cervical and Endometrial Cancer Survivors NIH Public Access","volume":"23","author":"Donovan","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.maturitas.2026.109004_bb0190","doi-asserted-by":"crossref","first-page":"143.e1","DOI":"10.1016\/j.ajog.2023.05.002","article-title":"Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women","author":"Tan-Kim","year":"2023","journal-title":"Am. J. Obstet. Gynecol., Elsevier Inc"},{"key":"10.1016\/j.maturitas.2026.109004_bb0195","series-title":"Efficacy and safety of an ultra-low-dose 0.005% estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: a randomized double-blind placebo-controlled trial","author":"Mui\u00f1os Fern\u00e1ndez","year":"2024"},{"key":"10.1016\/j.maturitas.2026.109004_bb0200","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.2011.38.0261","article-title":"Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer","volume":"30","author":"Henry","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1200\/JOP.18.00710","article-title":"Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy","volume":"15","author":"Sussman","year":"2019","journal-title":"J. Oncol. Pract."},{"key":"10.1016\/j.maturitas.2026.109004_bb0210","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/GME.0000000000001497","volume":"27","author":"Hirschberg","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2026.109004_bb0215","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jnci\/djac112","article-title":"Systemic or Vaginal Hormone Therapy after Early Breast Cancer: A Danish Observational Cohort Study","volume":"114","author":"Cold","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.maturitas.2026.109004_bb0220","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/AOG.0000000000005294","article-title":"Safety of Vaginal Estrogen Therapy for Genitourinary Syndrome of Menopause in Women With a History of Breast Cancer","volume":"142","author":"Agrawal","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0225","article-title":"Vaginal estrogen therapy use and survival in females with breast cancer","author":"McVicker","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ajog.2024.10.054","article-title":"Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks","volume":"232","author":"Beste","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2026.109004_bb0235","author":"FDA"},{"key":"10.1016\/j.maturitas.2026.109004_bb0240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/20533691231208473","article-title":"A systematic review of randomised clinical trials \u2013 the safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors","volume":"29","author":"Hussain","year":"2023","journal-title":"Post Reprod. Health"},{"key":"10.1016\/j.maturitas.2026.109004_bb0245","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.clbc.2023.08.003","article-title":"Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis","volume":"23","author":"Comini","year":"2023","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.maturitas.2026.109004_bb0250","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2020.06.021","article-title":"No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA)","volume":"142","author":"Cai","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109004_bb0255","first-page":"950","author":"Committee on Clinical Consensus\u2013Gynecology, M. and liaison E.E.M","year":"2021"},{"key":"10.1016\/j.maturitas.2026.109004_bb0260","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/13697137.2022.2050208","article-title":"Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study","volume":"25","author":"Mension","year":"2022","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2026.109004_bb0265","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/ijgc-2019-001034","article-title":"Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma","volume":"30","author":"Chambers","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.maturitas.2026.109004_bb0270","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_389516","article-title":"Shared Decision Making in the Care of Patients With Cancer","author":"Shickh","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.maturitas.2026.109004_bb0275","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.maturitas.2020.08.010","article-title":"Genitourinary Syndrome of Menopause: Current Treatment Options in Breast Cancer Survivors \u2013 Systematic Review","volume":"143","author":"Mension","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2026.109004_bb0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-016-3827-7","article-title":"Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy","volume":"157","author":"Sulaica","year":"2016","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:02:55Z","timestamp":1784761375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S0378512226001817"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109004","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genitourinary syndrome of menopause in women with cancer \u2013 a narrative review","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.109004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109004"}}